Evolent Health, Inc. EVH Equity in earnings (losses) of equity method investees
Equity in earnings (losses) of equity method investees at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s equity in earnings (losses) of equity method investees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s equity in earnings (losses) of equity method investees?
- Evolent Health, Inc. (EVH) reported equity in earnings (losses) of equity method investees of -$11K in Q1 2026.
- How has Evolent Health, Inc.'s equity in earnings (losses) of equity method investees changed year-over-year?
- Evolent Health, Inc.'s equity in earnings (losses) of equity method investees increased by 42.1% year-over-year, from -$19K to -$11K.
- What is the long-term trend for Evolent Health, Inc.'s equity in earnings (losses) of equity method investees?
- Over 4 years (2021 to 2025), Evolent Health, Inc.'s equity in earnings (losses) of equity method investees has grown at a -59.2% compound annual growth rate (CAGR), from $13.18M to $365K.